Literature DB >> 822887

Progressive effects of cocaine on behavior and central amine metabolism in rhesus monkeys: relationship to kindling and psychosis.

R M Post, R T Kopanda, K E Black.   

Abstract

Chronic administration of the same dose of cocaine to rhesus monkeys for up to 6 months was associated with progressive alterations in pathological behavior and increased susceptibility to seizures. Monkeys initially displaying prominent hyperactive stereotypic responses for up to 2 months began to demonstrate increasing amounts of inhibitory behavior, consisting of catalepsy, motor inhibition, and abnormal visual tracking and staring. Four of 13 animals developed increasing intensities of lingual-buccal dyskinesias after 10 weeks of chronic cocaine. Animals initially showing no convulsions to a given dose of cocaine eventually developed convulsions to the same dose, and then displayed an increased frequency of convulsions following subsequent injections. Levels of the dopamine metabolite, homovanillic acid (HVA), in the cisternal cerebrospinal fluid were significantly elevated during both excitatory stereotypic and inhibitory syndromes; a similar trend was observed for HVA after probenecid administration. Only the probenecid-induced accumulations of the serotonin metabolite 5-hydroxyindoleacetic acid, following acute cocaine administration, were significantly elevated. The progressive increases in convulsions, dyskinesias, and the inhibitory syndrome did not appear related to alterations in peak levels of cocaine in plasma or CSF, and a pharmacological kindling model is suggested as an alternate explanation of the data. The study extends the current models of stimulant-induced psychoses by highlighting the progressive alterations in behavior and neurological sequelae and in suggesting that this progressive mechanism may also be important in the development of psychosis in man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822887

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  17 in total

1.  Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use.

Authors:  C W Bradberry
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

2.  Repetitive behaviors in monkeys are linked to specific striatal activation patterns.

Authors:  Esen Saka; Claudia Goodrich; Patricia Harlan; Bertha K Madras; Ann M Graybiel
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

Review 3.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 4.  Effects of cocaine on the hypothalamic-pituitary-adrenal axis.

Authors:  L Manetti; F Cavagnini; E Martino; A Ambrogio
Journal:  J Endocrinol Invest       Date:  2014-05-23       Impact factor: 4.256

5.  Tolerance to and residual effects of cocaine in squirrel monkeys depend on reinforcement-schedule parameter.

Authors:  C E Hughes; M N Branch
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

6.  Cocaine tolerance: acute versus chronic effects as dependent upon fixed-ratio size.

Authors:  S H Hoffman; M N Branch; G M Sizemore
Journal:  J Exp Anal Behav       Date:  1987-05       Impact factor: 2.468

7.  Alterations in t-butylbicyclophosphorothionate binding in the brains of lidocaine-kindled rats.

Authors:  M S Abel; D E Carney
Journal:  Metab Brain Dis       Date:  1993-12       Impact factor: 3.584

8.  Assessment of dependence potential of drugs in humans using multiple indices.

Authors:  C E Johanson; K Kilgore; E H Uhlenhuth
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.

Authors:  E B Nielsen; M Nielsen; C Braestrup
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Repeated administration of subconvulsant doses of GABA antagonist drugs. I. Effect on seizure threshold (kindling).

Authors:  D J Nutt; P J Cowen; C C Batts; D G Grahame-Smith; A R Green
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.